Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors.
Grønvold BL, Ali MM, Myklebust TÅ, Lenartova A, Remberger M, Abrahamsen IW, Tjønnfjord GE, Myhre AE, Fløisand Y, Gedde-Dahl T.
Grønvold BL, et al. Among authors: ali mm.
EJHaem. 2024 Feb 5;5(1):117-124. doi: 10.1002/jha2.842. eCollection 2024 Feb.
EJHaem. 2024.
PMID: 38406518
Free PMC article.
Outcomes of 2-year survivours undergoing allo-haematopoietic stem cell transplantation at Oslo University Hospital were retrospectively assessed with the objectives of identification of risk factors for late death as possible means for precautionary measures and interventions to …
Outcomes of 2-year survivours undergoing allo-haematopoietic stem cell transplantation at Oslo University Hospital were retrospectively asse …